Michael H Schiff Selected Research

TNFR-Fc fusion protein (etanercept)

07/2008	Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: Results of a multicenter, randomized, double-blind, active drug-controlled study.
05/2006	Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
04/2006	Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.
01/2006	Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies.
08/2004	Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
06/2004	The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
02/2004	Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
04/2003	Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
06/2002	Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.

14	Rheumatoid Arthritis 07/2008 - 06/2002
1	Ankylosing Spondylitis 07/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2004

9	TNFR-Fc fusion protein (etanercept)FDA Link 07/2008 - 06/2002
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2005 - 01/2004
2	adalimumab (Humira)FDA Link 07/2006 - 12/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2005 - 12/2003
1	Antirheumatic Agents (DMARD)IBA 01/2006
1	Dehydroepiandrosterone (DHEA)IBA 09/2004
1	infliximab (Remicade)FDA Link 06/2004
1	Methotrexate (Mexate)FDA LinkGeneric 06/2002